Surveillance for Adverse Events Following Pandemic H1N1 Immunization
Short and Long-Term Electronic Surveillance of a Large Number of Healthcare Workers Following Administration of an Adjuvanted Ph1n1 Vaccine
Sponsor: Alberta Children's Hospital
This observational or N/A phase trial investigates Novel Influenza A/H1N1 and is currently completed. Alberta Children's Hospital leads this study, which shows 9 recorded versions since 2009 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
9 versions recorded-
Jan 2026 — Present [monthly]
Completed
-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
▶ Show 4 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Jul 2017 — Apr 2018 [monthly]
Completed NA
-
Jan 2017 — Jul 2017 [monthly]
Completed NA
First recorded
Oct 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Alberta Children's Hospital
- CHU de Quebec-Universite Laval
- GlaxoSmithKline
- Hamilton Health Sciences Corporation
- Institut National en Santé Publique du Québec
- Laval University
- Mount Sinai Hospital, New York
- PHAC/CIHR Influenza Research Network
- Queen Elizabeth II Health Sciences Centre
- The Ottawa Hospital
- Vancouver General Hospital
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.